Tuesday, December 20, 2016

UPDATE 2-Acadia says Alzheimer's psychosis drug clears mid-stage study

Dec 20 (Reuters) - Acadia Pharmaceuticals Inc said

on Tuesday its drug to treat psychosis in patients suffering

from Alzheimer's disease met its main goal in a mid-stage study.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)